• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION; AMPLATZER DUCT OCCLUDER II

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION; AMPLATZER DUCT OCCLUDER II Back to Search Results
Model Number 9-PDA2
Device Problem Malposition of Device (2616)
Patient Problems Death (1802); Vasoconstriction (2126); Rupture (2208)
Event Date 09/18/2015
Event Type  Injury  
Manufacturer Narrative
The following three reports are related: adoii -- mdr-2015-20687, this report.7f amplatzer torqvue 180 delivery system -- mdr-2015-19055, follow up report to pending submission.7f ultimum introducer -- mdr-2015-20693, pending submission.The results of the investigation are inconclusive since the adoii was not returned for analysis.A review of the device history record was not possible since the serial number was unavailable.Based on the information received, the cause of the reported incident could not be conclusively determined.Gtin: unknown as adoii lot/serial numbers are unknown.
 
Event Description
The patient's patent ductus arteriosus was accessed from the aortic side and a 6-6mm amplatzer duct occluder 2 (adoii) was deployed and released.The adoii was found to be protruding into the aorta after release.To facilitate removal of the adoii using a snare, the 5f amplatzer torqvue 180 delivery system (dtv180) was exchanged for a 7f dvt180 in the femoral artery.Through the larger sheath, the adoii was snared and removed without issue.It was reported that prior to removal of an ultimum 7f short femoral sheath, the vessel developed spasms and treatment included the administration of pharmacology agents to stop the spasms.As the ultimum 7f short sheath was removed, a rupture of the iliac artery reportedly occurred and emergency surgery was required.The patient expired secondary to bleeding complications during the hospital stay.The exact cause of death and patient co-morbidities are unknown.The relationship of sjm devices to the need for surgical intervention is unclear.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
AMPLATZER DUCT OCCLUDER II
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key5163267
MDR Text Key28826608
Report Number2135147-2015-00126
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeDA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Report Date 09/24/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Physician
Device Model Number9-PDA2
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/20/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age6 MO
-
-